Related references
Note: Only part of the references are listed.Population Pharmacokinetics, Tolerability, and Safety of Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine-Piperaquine in Pregnant and Nonpregnant Papua New Guinean Women
John M. Benjamin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Population Approach To Analyze the Pharmacokinetics of Free and Total Lopinavir in HIV-Infected Pregnant Women and Consequences for Dose Adjustment
Floris Fauchet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women
Minh P. Le et al.
ANTIVIRAL THERAPY (2015)
Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement
Salmaan Kanji et al.
CLINICAL PHARMACOKINETICS (2015)
Pharmacogenetics of Pregnancy-Induced Changes in Efavirenz Pharmacokinetics
A. Olagunju et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Pharmacokinetics of tenofovir during pregnancy and postpartum
B. M. Best et al.
HIV MEDICINE (2015)
Pharmacokinetics of nifedipine slow-release tablets during sustained tocolysis
Maureen A. ter Laak et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Alice Stek et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
Paracetamol pharmacokinetics and metabolism in young women
Karel Allegaert et al.
BMC ANESTHESIOLOGY (2015)
Atazanavir exposure is effective during pregnancy regardless of tenofovir use
Angela Colbers et al.
ANTIVIRAL THERAPY (2015)
Ondansetron Pharmacokinetics in Pregnant Women and Neonates: Towards a New Treatment for Neonatal Abstinence Syndrome
M. H. Elkomy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics
F. T. Aweeka et al.
HIV MEDICINE (2015)
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women
Angela Colbers et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Randomized Clinical Trial Comparing the Pharmacokinetics of Standard- and Increased- Dosage Lopinavir- Ritonavir Coformulation Tablets in HIV- Positive Pregnant Women
Marilia Santini-Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Population Pharmacokinetics and Clinical Response for Artemether-Lumefantrine in Pregnant and Nonpregnant Women with Uncomplicated Plasmodium falciparum Malaria in Tanzania
Dominic Mosha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics
Elodie Valade et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19
Alice Ban Ke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Pharmacokinetics of doxorubicin in pregnant women
Rachel J. Ryu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy
James H. Fischer et al.
CLINICAL PHARMACOKINETICS (2014)
Carbamazepine clearance and seizure stability during pregnancy
Emily L. Johnson et al.
EPILEPSY & BEHAVIOR (2014)
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
C. D. Zorrilla et al.
HIV MEDICINE (2014)
Raltegravir Pharmacokinetics During Pregnancy
D. Heather Watts et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso
Innocent Valea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
Frank Kloprogge et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Pharmacokinetics of Lopinavir/Ritonavir and Efavirenz in Food Insecure HIV-Infected Pregnant and Breastfeeding Women in Tororo, Uganda
Imke H. Bartelink et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy
P. G. J. ter Horst et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Pharmacotherapy for Mood Disorders in Pregnancy A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring
Kristina M. Deligiannidis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Physiologic and pharmacokinetic changes in pregnancy
Maged M. Costantine
FRONTIERS IN PHARMACOLOGY (2014)
Model-based lamotrigine clearance changes during pregnancy: clinical implication
Akshanth R. Polepally et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Obstetric pharmacokinetic dosing studies are urgently needed
Shelley A. McCormack et al.
FRONTIERS IN PEDIATRICS (2014)
Venous Thromboembolism and Antithrombotic Therapy in Pregnancy
Wee-Shian Chan et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2014)
Human Placental Lactogen Induces CYP2E1 Expression via PI3-Kinase Pathway in Female Human Hepatocytes
Jin Kyung Lee et al.
DRUG METABOLISM AND DISPOSITION (2014)
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
Angela P. H. Colbers et al.
AIDS (2013)
Lamotrigine Dosing for Pregnant Patients With Bipolar Disorder
Crystal T. Clark et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Reduced indinavir exposure during pregnancy
Tim R. Cressey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum
Aida Kulo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy
T. L. Reisinger et al.
EPILEPSY & BEHAVIOR (2013)
Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy
Regis Kreitchmann et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Steady-State Pharmacokinetics, Cord Blood Concentrations, and Safety of Ritonavir-Boosted Fosamprenavir in Pregnancy
Michelle S. Cespedes et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Protein Binding of Lopinavir and Ritonavir During 4 Phases of Pregnancy: Implications for Treatment Guidelines
Kristine B. Patterson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Comparing the Pharmacokinetics of Doxylamine/Pyridoxine Delayed-Release Combination in Nonpregnant Women of Reproductive Age and Women in the First Trimester of Pregnancy
Ilan Matok et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Pharmacologic evidence to support clinical decision making for peripartum methadone treatment
D. L. Bogen et al.
PSYCHOPHARMACOLOGY (2013)
Pharmacokinetics of High-Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka, Bangladesh
Daniel E. Roth et al.
NUTRIENTS (2013)
Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone
Su-Young Choi et al.
DRUG METABOLISM AND DISPOSITION (2013)
Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy
Leslie J. Dickmann et al.
DRUG METABOLISM AND DISPOSITION (2013)
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda
F. Kloprogge et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 Women
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma Concentrations
L. J. Else et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women
Sihem Benaboud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age
James H. Fischer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
Joel Tarning et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
Rose McGready et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Safety and Pharmacokinetics of Nelfinavir During the Second and Third Trimesters of Pregnancy and Postpartum
A. Fang et al.
HIV CLINICAL TRIALS (2012)
Efavirenz Pharmacokinetics During the Third Trimester of Pregnancy and Postpartum
Tim R. Cressey et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis
Aida Kulo et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women
Daniel E. Roth et al.
NUTRITION JOURNAL (2012)
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy
Leonardo Calza et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Thai HIV-1-infected women do not require a dose increase of lopinavir/ritonavir during the third trimester of pregnancy
Reshmie A. Ramautarsing et al.
AIDS (2011)
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women
Richard H. Beigi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Allen A. Mitchell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Falciparum Malaria
Marcus J. Rijken et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics of Amodiaquine and Desethylamodiaquine in Pregnant and Postpartum Women with Plasmodium vivax Malaria
Marcus J. Rijken et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy
J. S. Lambert et al.
HIV MEDICINE (2011)
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
F. Conradie et al.
HIV MEDICINE (2011)
A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories
Mary H. H. Ensom et al.
HUMAN REPRODUCTION (2011)
Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy
Mark Mirochnick et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Carrie A. Morris et al.
MALARIA JOURNAL (2011)
Pharmacokinetic Study of Saquinavir 500 mg Plus Ritonavir (1000/100 mg Twice a Day) in HIV-Positive Pregnant Women
Maria Martinez-Rebollar et al.
THERAPEUTIC DRUG MONITORING (2011)
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study
Kristel Van Calsteren et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
Pregnancy outcome at extremely advanced maternal age
Yariv Yogev et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Pharmacokinetic Properties of Azithromycin in Pregnancy
Sam Salman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics of Chloroquine and Monodesethylchloroquine in Pregnancy
Harin A. Karunajeewa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy
M. M. Nyunt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Comparison of Pharmacokinetic Profiles of Moxifloxacin in Caesarean versus Non-Pregnant Sectioned Women by Fully Validated HPLC with Fluorescence Detection
Emirhan Nemutlu et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2010)
Pharmacokinetics of Metformin during Pregnancy
Sara Eyal et al.
DRUG METABOLISM AND DISPOSITION (2010)
Lopinavir protein binding in HIV-1-infected pregnant women
F. T. Aweeka et al.
HIV MEDICINE (2010)
Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women
Mohammed Lamorde et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy
Brookie M. Best et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women
Harin A. Karunajeewa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs
Gail D. Anderson et al.
CLINICAL PHARMACOKINETICS (2009)
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)
D. Hirt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Clonidine Pharmacokinetics in Pregnancy
M. L. Buchanan et al.
DRUG METABOLISM AND DISPOSITION (2009)
Up-Regulation of UDP-Glucuronosyltransferase (UGT) 1A4 by 17β-Estradiol: A Potential Mechanism of Increased Lamotrigine Elimination in Pregnancy
Huiqing Chen et al.
DRUG METABOLISM AND DISPOSITION (2009)
Serum concentration/dose ratio of topiramate during pregnancy
Andreas Austgulen Westin et al.
EPILEPSIA (2009)
Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: Clinical and outcome implications
Isabel P. Lopez-Fraile et al.
EPILEPSY & BEHAVIOR (2009)
Seizure deterioration in women treated with oxcarbazepine during pregnancy
Vaiva Petrenaite et al.
EPILEPSY RESEARCH (2009)
Pharmacokinetics of topiramate during pregnancy
Inger Ohman et al.
EPILEPSY RESEARCH (2009)
Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period
Christina Fotopoulou et al.
EPILEPSY RESEARCH (2009)
Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment
Marion Bouillon-Pichault et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
CEFAZOLIN PLASMA PROTEIN BINDING SATURABILITY DURING PREGNANCY
Karel Allegaert et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2009)
Hypoglycemics: Pharmacokinetic Considerations During Pregnancy
Chagit Klieger et al.
THERAPEUTIC DRUG MONITORING (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women
Matthieu Roustit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy
C. Lebaudy et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: A University of Washington specialized center of research study
M. F. Hebert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Antiepileptic drugs during pregnancy: What is known and which AEDs seem to be safest?
Page B. Pennell
EPILEPSIA (2008)
Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy
Inger Ohman et al.
EPILEPSIA (2008)
Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy
Joshua J. Gagne et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria
Sue Jean Lee et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353
Y. J. Bryson et al.
HIV CLINICAL TRIALS (2008)
Steady-state nevirapine plasma concentrations are influenced by pregnancy
J. F. J. B. Nellen et al.
HIV MEDICINE (2008)
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
E. V. Capparelli et al.
HIV MEDICINE (2008)
Lopinavir Exposure With an Increased Dose During Pregnancy
Mark Mirochnick et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
Dorothy K. Sit et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Pharmacokinetics of Sertraline Across Pregnancy and Postpartum
Marlene P. Freeman et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Serum concentration/dose ratio of levetiracetam before, during and after pregnancy
Andreas Austgulen Westin et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2008)
Lamotrigine in pregnancy: Clearance, therapeutic drug monitoring, and seizure frequency
P. B. Pennell et al.
NEUROLOGY (2008)
Pharmacokinetic studies in pregnant women
G. J. Anger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women
J. Popovic et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer
Diego Ripamonti et al.
AIDS (2007)
What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research
Thomas W. Mcdade et al.
DEMOGRAPHY (2007)
Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in western Kenya
Michael D. Green et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Amoxicillin pharmacokinetics in pregnant women: Modeling and simulations of dosage strategies
M. A. Andrew et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
Jashvant D. Unadkat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetics of quinine and its metabolites in pregnant Sudanese women with uncomplicated Plasmodium falciparum malaria
I. I. Abdelrahim et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation
Torbjorn Tomson et al.
EPILEPSIA (2007)
Pharmacokinetics of oral cefatrizine in pregnant and non-pregnant women with reference to fetal distribution
N. Papantoniou et al.
FETAL DIAGNOSIS AND THERAPY (2007)
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria
Rose McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation
Gail D. Anderson
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Oxcarbazepine concentrations during pregnancy: A retrospective study in patients with epilepsy
Jakob Christensen et al.
NEUROLOGY (2006)
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
P. Villani et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women
D Hirt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands
MK Bakker et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium
I Mazzucchelli et al.
EPILEPSIA (2006)
Effect of pregnancy on the pharmacokinetics of metformin
RCE Hughes et al.
DIABETIC MEDICINE (2006)
Population pharmacokinetics of metformin in late pregnancy
B Charles et al.
THERAPEUTIC DRUG MONITORING (2006)
Changes to methadone clearance during pregnancy
K Wolff et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Use of over-the-counter medications during pregnancy
MM Werler et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Individual changes in lamotrigine plasma concentrations during pregnancy
V Petrenaite et al.
EPILEPSY RESEARCH (2005)
Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach
GD Anderson
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetics and pharmacodynamics of Atenolol during pregnancy and postpartum
MF Hebert et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Evidence for increased metabolism of chloroquine during the early third trimester of human pregnancy
MC Chukwuani et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2004)
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
EP Acosta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The impact of pregnancy and childbirth on the metabolism of lamotrigine
PB Pennell et al.
NEUROLOGY (2004)
Nelfinavir plasma concentrations are low during pregnancy
JFJB Nellen et al.
CLINICAL INFECTIOUS DISEASES (2004)
A prospective triat that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levets of anticoagulation
LA Barbour et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
MHH Ensom et al.
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION (2004)
Gestation-induced changes in lamotrigine pharmacokinetics:: A monotherapy study
GJ de Haan et al.
NEUROLOGY (2004)
Prescription drug use in pregnancy
Susan E. Andrade et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum
RPG van Heeswijk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria
R McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil
R McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Antiepileptic drug pharmacokinetics during pregnancy and lactation
PB Pennell
NEUROLOGY (2003)
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
BW Kosel et al.
AIDS (2003)
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
T Heikkinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population
DD Glover et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Treatment of primary hypothyroidism during pregnancy: Is there an increase in thyroxine dose requirement in pregnancy?
IJ Chopra et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Citalopram in pregnancy and lactation
T Heikkinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Treatment of epilepsy in women of reproductive age - Pharmacokinetic considerations
JW McAuley et al.
CLINICAL PHARMACOKINETICS (2002)
The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans
K Tsutsumi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
